← Back to headlines
Abbott Laboratories Stock Falls as Guidance and Litigation Concerns Overshadow Growth
Abbott Laboratories (ABT) stock experienced a decline as investor concerns over its guidance and ongoing litigation overshadowed positive growth indicators.
27 Jul, 12:41 — 27 Jul, 12:41
Sources
Showing 1 of 1 sources
